Search research articles
Contact Us
Filters
Showing results (301-310 of 387) with videos related to
Page
of 39
Sort By:
Blood
|
February 6, 2014
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang, Andrew L Feldman, David A Wada, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
Cancer Causes & Control : CCC
|
May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
Jennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
American Journal of Hematology
|
February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
N Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
Blood Advances
|
October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
Alessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Advances
|
July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Aung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Blood Cancer Journal
|
November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Allison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
Matthew T Drake, Matthew J Maurer, Brian K Link, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 387) with videos related to
Sort By:
Page
of 39
Blood
|
February 6, 2014
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang, Andrew L Feldman, David A Wada, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
Cancer Causes & Control : CCC
|
May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
Jennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
American Journal of Hematology
|
February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
N Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
Blood Advances
|
October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
Alessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Advances
|
July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Aung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Blood Cancer Journal
|
November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Allison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
Matthew T Drake, Matthew J Maurer, Brian K Link, et al.
Page
of 39